close
Investment
1 mins to read

Ebos shares to resume trading after rumoured deal falls over

Ebos went into a trading halt last Thursday ahead of a potential deal for pets and vets business.

Ebos chief executive John Cullity.

Trading in shares of dual-listed healthcare product company Ebos will resume this morning after the company said that a rumoured multi-billion dollar acquisition will not proceed.

Last Thursday, Ebos went into a trading halt after the Australian Financial Review reported it was eyeing up a deal for

Want to read more? It's easy.

Choose your best value subscription option

Student

NZ uni students have FREE access (valued at $499) to NBR in 2024.
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
Contact the Writer: Hmcnicol@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Ebos shares to resume trading after rumoured deal falls over
Investment,
101779